Navigation Links
Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII
Date:11/11/2009

ss Unit. "FOCUS was born out of the understanding that each patient manages his or her day differently. FOCUS provides customized support for patients taking Vyvanse, so that in addition to working with their doctor on a comprehensive treatment plan, patients also have a resource for helpful tips that they can use throughout their day both at work and at home."

Vyvanse is indicated for the treatment of ADHD in children aged 6 to 12 and in adults with ADHD. The most common side effects reported in studies of Vyvanse in adults were decreased appetite, difficulty falling asleep and dry mouth. The symptoms of ADHD in adults, such as inattention, hyperactivity, and impulsivity, may result in having trouble focusing, avoiding tasks that require sustained mental efforts, or frequently losing things.

To learn more about FOCUS, visit http://www.vyvanseFOCUS.com. Additional information about Vyvanse and Full Prescribing Information, including Medication Guide, are available at http://www.vyvanse.com.

About Vyvanse

Vyvanse is indicated for the treatment of ADHD. Efficacy based on two controlled trials in children aged 6 to 12 and one controlled trial in adults.

Tell the doctor about any heart conditions, including structural abnormalities, that you, your child, or a family member, may have. Inform the doctor immediately if you or your child develops symptoms that suggest heart problems, such as chest pain or fainting.

Vyvanse should not be taken if you or your child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or un
'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
2. Shire Continues to Deliver Excellent Growth From Core Products
3. Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
4. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
5. Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA
6. Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
7. Veriscrip and DAMMAD Team Up to Combat Prescription Drug Abuse in New Hampshire
8. New Hampshire Rx Card Launching Statewide
9. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
10. Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
11. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014  The American Diabetes Association ... target for people with diabetes and that all ... doses of statins, in keeping with recent changes ... the American College of Cardiology (ACC) and American ... the most recent changes to the Association,s annual ...
(Date:12/22/2014)... 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical ... purification technology to help fight deadly inflammation in ... worldwide, today announced the appointment of Dr. ... its Senior Vice President of Clinical Development, effective ... Di Russo is an accomplished pediatric cardiothoracic ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
Breaking Medicine Technology:New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5Investment Analysis of the US Medical Device Sector 2
... BIRMINGHAM, Ala., Jan. 23 BioCryst,Pharmaceuticals, Inc. ... update on activities,conducted following release of the ... clinical development plan for intramuscular (i.m.) peramivir., ... Following release of preliminary Phase II results ...
... This Month ... at the University of Kentucky, LEXINGTON, Ky., ... on Aging are launching an Alzheimer,s,screening clinical trial with Neuronetrix,s ... assessments,using a technology called event-related potentials (ERP,s). The study is,expected ...
Cached Medicine Technology:BioCryst Updates Peramivir Clinical Development Plan 2BioCryst Updates Peramivir Clinical Development Plan 3BioCryst Updates Peramivir Clinical Development Plan 4BioCryst Updates Peramivir Clinical Development Plan 5BioCryst Updates Peramivir Clinical Development Plan 6Innovative Brain Scanning for Alzheimer's Screening Unveiled 2
(Date:12/25/2014)... 25, 2014 When head lice hits a ... a frenzy to get rid of it while keeping it ... Coral Gables now have the solution right in their neighborhood: ... location, Lice Troopers provides full spectrum head lice screening and ... area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest ...
(Date:12/25/2014)... The risk of burns from fires and cooking accidents ... extra cautious, an expert says. "Between Thanksgiving and ... patients coming in with burns," said Dr. Steven Sandoval, ... Center of Stony Brook University Hospital in New York. ... if not careful, could quickly turn tragic," Sandoval said ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... could be closing in on a "fountain of youth" drug ... health of older adults, a new study suggests. Seniors ... a drug that targets a genetic signaling pathway linked to ... report. The experimental medication, a version of ...
(Date:12/25/2014)... 25, 2014 “ SmileStix ” was featured ... the latest and coolest mobile applications on the iOS, Android, ... host of NewsWatch, conducted the app review and shared with ... personal stickers. , The old saying goes, “A picture says ... words that can describe a single image, because each picture ...
(Date:12/25/2014)... 25, 2014 Each year trauma accounts ... million hospital admissions across the nation (according to ... CDC’s National Hospital Ambulatory Medical Care Survey ... conducted in 2010. They estimated that there were between ... in a primary diagnosis of broken bone or fracture. ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... 9 Genomma Lab Internacional, S.A.B. de C.V. ... leading Mexican over-the-counter ("OTC") pharmaceuticals and personal care products ... initiate the operation of a stock repurchase fund according ... Directors for an amount of up to Ps. 100 ...
... Nash Corporation (Nasdaq: KNSY ) today announced ... second quarter ended December 31, 2008 at 7:30 A.M. ... Kaufmann, President and CEO, will be hosting a teleconference ... at 9:00 A.M. Eastern Time. To participate in ...
... for immunized seniors, study found, , , FRIDAY, Jan. 9 (HealthDay ... every year could cut your risk of dying from flu ... isn,t always a perfect match for the strains circulating in ... Medicine study that included 10 flu seasons, worth of ...
... but they could signal later trouble , , FRIDAY, Jan. ... to worry about whether their disease might slow their ... function are accelerated among those with the blood sugar ... issue of Neuropsychology , scientists from the University ...
... Jan. 9 The New Combituck(TM) procedure brings the ... tummy tuck, or abdominoplasty, has been the only option ... after weight fluctuations or child birth. A new procedure, ... abdominal skin and fat layer, without the weeks off ...
... the Centers for Medicare and Medicaid Services (CMS) released ... national coverage determination (NCD). This proposed legislation would allow ... patients with all types of cancer. The proposed decision ... addition to initial diagnosis. Two important items in the ...
Cached Medicine News:Health News:Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference 2Health News:You're Never Too Old for a Flu Shot 2Health News:You're Never Too Old for a Flu Shot 3Health News:Diabetes Linked to Cognitive Problems 2Health News:Doctors at Allure Medical Spa Are Getting the Results of a Tummy Tuck Without the Downtime 2Health News:SNM praises CMS decision to expand reimbursement for cancer treatment 2
... IMMULITE 2000 assays are ... the IMMULITE 2000, a ... immunoassay analyzer. IMMULITE 2000 ... centralization, and a rapidly ...
... CARDIAC M Myoglobin assay for use ... The Cardiac reader analyzer is a ... include: always ready to use (stand-by ... batch specific data entered automatically using ...
IRMA kit for detection of the cardiac marker Myoglobin...
... The CALBIOTECH INC. (CBI) Prolactin ELISA kit ... prolactin in human serum or plasma. Human ... polypeptide hormone with a molecular weight of ... based on a solid phase direct sandwich ...
Medicine Products: